SCHEMBL11296049

SCHEMBL11296049

N#Cc1ccc(N(c2ccc(C(=O)NO)cc2)C2CCNC2=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 7/20 0.45
▸ HDAC1 Q13547 6/20 0.45
▸ HDAC8 Q9BY41 5/20 0.45
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ EPHX2 P34913 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ KDM1A O60341 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ ADAM17 P78536 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ SMPD1 P17405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297505 0.89 HDAC8 (0.37) HDAC6HDAC1HDAC8NPC1RAB9A
SCHEMBL11305647 0.85 HDAC6 (0.41) HDAC6HDAC1HDAC8NPC1RAB9A
SCHEMBL11301754 0.85 PSEN1 (0.42) HDAC6HDAC1HDAC8ALDH1A1
SCHEMBL11297375 0.84 HDAC8 (0.44) HDAC6HDAC1HDAC8NPC1LMNA
SCHEMBL11303328 0.82 HDAC8 (0.37) HDAC6HDAC1HDAC8RAB9ALMNA
SCHEMBL11299083 0.82 HDAC6 (0.42) HDAC6HDAC1HDAC8NPC1RAB9A
SCHEMBL11296107 0.81 HDAC8 (0.45) HDAC6HDAC1HDAC8RAB9AKMT2A
SCHEMBL11296595 0.81 HDAC6 (0.42) HDAC6HDAC1HDAC8
SCHEMBL11297519 0.81 HDAC6 (0.43) HDAC6HDAC1HDAC8NPC1RAB9A
SCHEMBL11304336 0.81 HDAC6 (0.42) HDAC6HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback